日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data

吡咯替尼治疗HER2阳性转移性乳腺癌合并脑转移患者:真实世界多中心数据的探索性最终分析

Anwar, Munawar; Chen, Qitong; Ouyang, Dengjie; Wang, Shouman; Xie, Ning; Ouyang, Quchang; Fan, Peizhi; Qian, Liyuan; Chen, Gannong; Zhou, Enxiang; Guo, Lei; Gu, Xiaowen; Ding, Boning; Yang, Xiaohong; Liu, Liping; Deng, Chao; Xiao, Zhi; Li, Jing; Wang, Yunqi; Zeng, Shan; Hu, Jinhui; Zhou, Wei; Qiu, Bo; Wang, Zhongming; Weng, Jie; Liu, Mingwen; Li, Yi; Tang, Tiegang; Wang, Jianguo; Zhang, Hui; Dai, Bin; Tang, Wuping; Wu, Tao; Xiao, Maoliang; Li, Xiantao; Liu, Hailong; Li, Lai; Yi, Wenjun

miR-937-5p targets SOX17 to modulate breast cancer cell cycle and cell proliferation through the Wnt signaling pathway

miR-937-5p 靶向 SOX17 通过 Wnt 信号通路调节乳腺癌细胞周期和细胞增殖

Xiang Xiong, Wendi Xu, Jia Gong, Liwen Wang, Mei Dai, Gannong Chen, Liqin Yuan

MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells

MicroRNA-375靶向PAX6,抑制人乳腺癌MCF-7细胞的活力、迁移和侵袭。

Zou, Qiongyan; Yi, Wenjun; Huang, Jianghai; Fu, Fenfen; Chen, Gannong; Zhong, Dewu

MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells

MicroRNA-375 靶向 PAX6 并抑制人乳腺癌 MCF-7 细胞的活力、迁移和侵袭

Qiongyan Zou, Wenjun Yi, Jianghai Huang, Fenfen Fu, Gannong Chen, Dewu Zhong

Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis

吉非替尼维持治疗局部晚期/转移性非小细胞肺癌(EGFR突变未知)的经济效益:半马尔可夫模型分析

Zeng, Xiaohui; Li, Jianhe; Peng, Liubao; Wang, Yunhua; Tan, Chongqing; Chen, Gannong; Wan, Xiaomin; Lu, Qiong; Yi, Lidan